Nkcfo LLC Catalyst Pharmaceuticals, Inc. Transaction History

Nkcfo LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 26, 2023	SELL	$12.25 - $19.5 $10,412 - $16,575	-850 Reduced 7.39%	10,650 $198,000
Q3 2022 Oct 19, 2022	BUY	$7.06 - $15.52 $81,190 - $178,480	11,500 New	11,500 $148,000
Q2 2022 Jul 08, 2022	SELL	$6.23 - $8.57 $74,760 - $102,840	-12,000 Closed	0 $0
Q1 2022 Apr 28, 2022	BUY	$5.31 - $8.31 $63,719 - $99,720	12,000 New	12,000 $99,000

326

94.6M

19.1K

51.1K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.12B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Nkcfo LLC, based on Form 13F filings with the SEC.

Stay updated on Nkcfo LLC with notifications on news.